The MUSC SCORE is building on the findings from the most recent funding period and expanding the focus on sex and gender differences in addictions as well as the stress/addictions relationship in opioid and cannabis dependence, substances that are increasingly problematic in the United States today. Preclinical and clinical studies will focus on mechanistic underpinnings and potential sex and gender-specific therapeutic approaches.
●Basic Science Component
Drs. Peter Kalivas & Carmela Reichel
●Clinical Research Components
Drs. Aimee McRae-Clark & Michael Saladin- Cannabis Use Disorder
Drs. Kathleen Brady & Connie Guille- Opioid Use Disorder